429 related articles for article (PubMed ID: 23607771)
1. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
2. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
[TBL] [Abstract][Full Text] [Related]
3. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
[TBL] [Abstract][Full Text] [Related]
4. Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome.
Yin H; Vosters JL; Roescher N; D'Souza A; Kurien BT; Tak PP; Chiorini JA
PLoS One; 2011 Mar; 6(3):e18003. PubMed ID: 21464925
[TBL] [Abstract][Full Text] [Related]
5. Immunization with peptides from 60 kDa Ro in diverse mouse strains.
Scofield RH; Pierce PG; James JA; Kaufman KM; Kurien BT
Scand J Immunol; 2002 Nov; 56(5):477-83. PubMed ID: 12410797
[TBL] [Abstract][Full Text] [Related]
6. Induction of oral tolerance in experimental Sjogren's syndrome autoimmunity.
Kurien BT; Asfa S; Li C; Dorri Y; Jonsson R; Scofield RH
Scand J Immunol; 2005 May; 61(5):418-25. PubMed ID: 15882433
[TBL] [Abstract][Full Text] [Related]
7. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
8. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein.
Stathopoulou EA; Routsias JG; Stea EA; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2005 Jul; 141(1):148-54. PubMed ID: 15958081
[TBL] [Abstract][Full Text] [Related]
9. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
10. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules.
Paisansinsup T; Deshmukh US; Chowdhary VR; Luthra HS; Fu SM; David CS
J Immunol; 2002 Jun; 168(11):5876-84. PubMed ID: 12023392
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.
Scofield RH; Farris AD; Horsfall AC; Harley JB
Arthritis Rheum; 1999 Feb; 42(2):199-209. PubMed ID: 10025913
[TBL] [Abstract][Full Text] [Related]
12. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects.
Mavragani CP; Tzioufas AG; Moutsopoulos HM
Int Arch Allergy Immunol; 2000 Sep; 123(1):46-57. PubMed ID: 11014971
[TBL] [Abstract][Full Text] [Related]
13. MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production.
Wahren M; Skarstein K; Blange I; Pettersson I; Jonsson R
Immunology; 1994 Sep; 83(1):9-15. PubMed ID: 7821973
[TBL] [Abstract][Full Text] [Related]
14. Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction.
Sroka M; Bagavant H; Biswas I; Ballard A; Deshmukh US
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):41-46. PubMed ID: 29465352
[TBL] [Abstract][Full Text] [Related]
15. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
[TBL] [Abstract][Full Text] [Related]
16. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
[TBL] [Abstract][Full Text] [Related]
17. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
[TBL] [Abstract][Full Text] [Related]
18. Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjögren's syndrome.
Beer RG; Rischmueller M; Coates T; Purcell AW; Keech CL; McCluskey J; Gordon TP
Clin Immunol Immunopathol; 1996 Jun; 79(3):314-8. PubMed ID: 8635291
[TBL] [Abstract][Full Text] [Related]
19. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
20. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
